About
Drugs for pediatric neurological conditions
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
369
By Phase
PHASE2/PHASE3: 1PHASE1/PHASE2: 1PHASE3: 1
By Status
UNKNOWN: 1WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04217278Collaborator
A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT
PHASE2/PHASE3Unknown
333 participants
Started: Jan 27, 2020 · Completed: Mar 31, 2025
NCT02724904Collaborator
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
PHASE1/PHASE2Withdrawn
Started: May 31, 2017 · Completed: Dec 31, 2021
NCT02411084Lead Sponsor
"Study of BEGEDINA® vs Conventional Treatment for Treating Steroid-Resistant Acute GvHD"
PHASE3Terminated
36 participants
Started: Feb 29, 2016 · Completed: Jul 31, 2017
Locations (1)
Headquarters
Paris, France
Map
Loading map...